American Capital Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07K Hold
52
﹤0.01% 474
2026
Q1
$4.51K Buy
52
+11
+27% +$1.05K ﹤0.01% 408
2025
Q4
$3.94K Buy
41
+14
+52% +$1.36K ﹤0.01% 393
2025
Q3
$2.57K Buy
27
+3
+13% +$276 ﹤0.01% 405
2025
Q2
$2.09K Buy
24
+8
+50% +$678 ﹤0.01% 405
2025
Q1
$1.44K Buy
+16
New +$1.43K ﹤0.01% 405

Other funds holding MDT

American Capital Advisory's MDT Position: Q2 2026 in Review

American Capital Advisory held its Medtronic (MDT) position steady in Q2 2026 at 52 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #474.

American Capital Advisory first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.51K in Q1 2026. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • American Capital Advisory held 52 shares of Medtronic worth $4.07K as of Q2 2026.
  • American Capital Advisory left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #474 holding.
  • American Capital Advisory first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • American Capital Advisory's Medtronic position peaked at $4.51K in Q1 2026.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.